Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Icu Medical (ICUI) EBITDA Margin (2016 - 2025)

Icu Medical's EBITDA Margin history spans 17 years, with the latest figure at 1.04% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 494.0% year-over-year to 1.04%, compared with a TTM value of 1.92% through Dec 2025, up 12.0%, and an annual FY2025 reading of 1.92%, up 12.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 1.04% at Icu Medical, down from 2.55% in the prior quarter.
  • The five-year high for EBITDA Margin was 11.42% in Q3 2021, with the low at 7.76% in Q1 2022.
  • Average EBITDA Margin over 5 years is 2.41%, with a median of 1.53% recorded in 2024.
  • Year-over-year, EBITDA Margin plummeted -1612bps in 2022 and then soared 941bps in 2023.
  • Tracing ICUI's EBITDA Margin over 5 years: stood at 7.0% in 2021, then tumbled by -101bps to 0.04% in 2022, then plummeted by -5296bps to 2.07% in 2023, then surged by 389bps to 5.98% in 2024, then crashed by -83bps to 1.04% in 2025.
  • Per Business Quant, the three most recent readings for ICUI's EBITDA Margin are 1.04% (Q4 2025), 2.55% (Q3 2025), and 1.93% (Q2 2025).